Pacira BioSciences, Inc. Common Stock (PCRX) is a publicly traded Healthcare sector company. As of September 15, 2026, PCRX trades at $24.06 with a market cap of $1.01B and a P/E ratio of 71.80. PCRX moved -1.09% today. Year to date, PCRX is -4.64%; over the trailing twelve months it is -9.00%. Its 52-week range spans $18.80 to $27.66. Analyst consensus is moderatebuy with an average price target of $28.67. Rallies surfaces PCRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest PCRX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $24.06 |
| Market Cap | $1.01B |
| P/E Ratio | 71.80 |
| EPS | $0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.66 |
| 52-Week Low | $18.80 |
| Volume | 69.54K |
| Avg Volume | 0 |
| Revenue (TTM) | $746.16M |
| Net Income | $14.64M |
| Gross Margin | 79.21% |
7 analysts cover PCRX: 0 strong buy, 3 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $28.67.